Understanding Chronic Lymphocytic Leukemia
Recruiting now
Conditions studied: Chronic Lymphocytic Leukemia
In brief
The purpose of this study is to collect human Chronic Lymphocytic Leukemia tissue samples and medical information, in order to find out more about the causes and biology of chronic lymphocytic leukemia.
Key facts
- Study ID
- NCT04028531
- Run by
- Dana-Farber Cancer Institute
- People needed
- 2750
- Starts
- 1999-09-29
- Expected to finish
- 2032-09-29
- Last updated by the study team
- 2026-04-24
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- New and existing patients seen for treatment of monoclonal B-cell lymphocytosis
- Any low grade lymphoproliferative disorder
- Chronic Lymphocytic Leukemia in the Dana Farber Cancer Institute Hematologic Oncology Clinic or elsewhere
Where it is running
- Dana Farber Cancer Institute — Boston, Massachusetts, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.